August 03, 2018
A Pennsylvania federal judge has tossed an investor suit against drugmaker Egalet Corp., ruling the company couldn't have known for certain when touting its opioid pill that a competitor's drug would have kept the product from being marketed as abuse-resistant and caused its stock to drop.